Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Modified-Release Drug Delivery Systems: Site-Targeted

Modified-Release Drug Delivery Systems: Site-Targeted

Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Magneto-Electrochemical Nanobioelectronic Device for Simultaneous Extraction and On-chip Detection of Cancer Biomarker in Cell Lysate.

Small (Weinheim an der Bergstrasse, Germany)·2026

Same author

Bio-conjugated ultrabright fluorescent nanoparticles for targeted cancer-cell imaging: independent size control and brightness.

Nanoscale·2026

Same author

Transport of Engineered Nanoparticles in Solid Tumors: Mechanistic Barriers and Emerging Delivery Strategies.

Bioconjugate chemistry·2026

Same author

Wearable near-infrared LED photothermal microneedle patch reduces periorbital wrinkles in a randomized pilot clinical trial.

Journal of materials chemistry. B·2026

Same author

Materials-Guided Gene-Ionizable Lipid Nanoparticles to Reverse Iron-Associated Immune Resistance in Renal Cancer.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026

Same author

Immunomodulatory Nanomaterials: Design Strategies, Mechanisms, Biomedical Applications, and Future Perspectives.

Biomedicines·2026

Search research articles

Related Experiment Video

Updated: Jun 28, 2026

Solid Lipid Nanoparticles SLNs for Intracellular Targeting Applications

Solid Lipid Nanoparticles SLNs for Intracellular Targeting Applications

Published on: November 17, 2015

Engineered Liposomes in Interventional Theranostics of Solid Tumors.

Nagavendra Kommineni¹, Ruchita Chaudhari², João Conde³

¹Center for Biomedical Research, Population Council, New York, New York 10065, United States.

ACS Biomaterials Science & Engineering

|July 14, 2023

Summary

Engineered liposomal nanoparticles show promise for cancer theranostics, enabling targeted delivery of therapies and imaging agents. Surface modifications improve tumor selectivity and therapeutic efficacy, addressing key challenges for clinical translation.

Keywords:

interventional theranostic liposomes nanoimaging solid tumors

More Related Videos

Spatial Measurements of Perfusion, Interstitial Fluid Pressure and Liposomes Accumulation in Solid Tumors

Spatial Measurements of Perfusion, Interstitial Fluid Pressure and Liposomes Accumulation in Solid Tumors

Published on: August 18, 2016

Using In Vitro Live-cell Imaging to Explore Chemotherapeutics Delivered by Lipid-based Nanoparticles

Using In Vitro Live-cell Imaging to Explore Chemotherapeutics Delivered by Lipid-based Nanoparticles

Published on: November 1, 2017

Related Experiment Videos

Last Updated: Jun 28, 2026

Solid Lipid Nanoparticles SLNs for Intracellular Targeting Applications

Solid Lipid Nanoparticles SLNs for Intracellular Targeting Applications

Published on: November 17, 2015

Spatial Measurements of Perfusion, Interstitial Fluid Pressure and Liposomes Accumulation in Solid Tumors

Spatial Measurements of Perfusion, Interstitial Fluid Pressure and Liposomes Accumulation in Solid Tumors

Published on: August 18, 2016

Using In Vitro Live-cell Imaging to Explore Chemotherapeutics Delivered by Lipid-based Nanoparticles

Using In Vitro Live-cell Imaging to Explore Chemotherapeutics Delivered by Lipid-based Nanoparticles

Published on: November 1, 2017

Area of Science:

Nanotechnology and Biomedical Engineering
Oncology and Pharmaceutical Sciences

Background:

Liposomal nanoparticles are advanced drug delivery systems with proven efficacy in cancer care.
Liposomal theranostics integrate diagnostic and therapeutic agents for enhanced cancer treatment.
Market-approved liposomal systems highlight their clinical relevance.

Purpose of the Study:

To review the significance and challenges of liposomal nanoparticles in targeted cancer theranostics.
To provide an overview of preclinical and clinical advancements in liposomal cancer therapy.
To discuss the translational aspects of liposomal theranostics for solid tumors.

Main Methods:

Review of existing literature on liposomal nanoparticles in cancer theranostics.
Analysis of engineering approaches to enhance liposome performance.
Evaluation of preclinical and clinical progress and translational challenges.

Main Results:

Engineered liposomes demonstrate improved tumor selectivity and therapeutic activity.
Surface modifications can overcome limitations like cargo leakage and poor targeting.
Several liposomal hybrid systems have gained FDA approval and market access.

Conclusions:

Liposomal theranostics offer a promising platform for targeted cancer treatment, combining imaging and therapy.
Overcoming challenges in stability, targeting, and cargo retention is crucial for widespread clinical adoption.
Continued research and engineering advancements are vital for realizing the full potential of liposomal medicines in oncology.